Dr. Kale received his PhD in Biophysics from Brandeis University in 2012. He worked as a postdoctoral fellow at the University of Chicago and at the US National Institutes of Health in Bethesda, Maryland. In 2019, he joined Izmir Biomedicine and Genome Center as a research group leader in Computational Biophysics. In 2023, he also assumed a joint affiliation as an assistant professor in the Faculty of Medicine of Izmir Katip Celebi University. Dr. Kale's lab uses high performance computing, molecular modeling, bioinformatics, and statistical physics to develop mechanistic understanding into disease etiologies, and how to alter such pathologies using small ligands and peptides. Dr. Kale is a recipient of the 2022 Installation Grant of the European Molecular Biology Organization, and multiple recipient of high performance computing time grants by the EuroHPC, EuroCC and PRACE consortia.